Nanox Installs a Second CFO and a Familiar Excuse: Commercialization Is Late — Again
A micro-cap imaging story where the headline isn't growth, it's a fresh CFO, a $2M cost-cut promise, and a Q&A room so thin you can hear the speakerphone echo.
NNOX · Earnings Call · 2026-09-09
The Cash Story Is Wearing the Growth Story's Clothes
Nano-X Imaging reported Q2 2026 on September 9th with a management table that had quietly turned over: Guy Nathanzon is the new Chief Financial Officer, replacing Ran Daniel, who as recently as April was joking on the call about not being done yet — “But don't give me yet. I have another one earnings call.” — Ran Daniel, Chief Financial Officer · 2026-04-20 He didn't make it to this one. Nathanzon opened his debut with a line that reads like a mandate: “we've also sought various ways to extend our cash runway to the point where we are at a sustainable run rate. During the quarter and subsequently, we have taken deliberate steps to implement effective measures, including reduction to our cash expenditures and cash burn.” — Guy Nathanzon, Chief Financial Officer · 2026-09-09 That is the tell. The quarter's real theme is not revenue — it is operating expense discipline layered over a now-familiar admission from CEO Erez Meltzer: “as we discussed last quarter, our commercialization has taken longer than we expected.” — Erez Meltzer, Chief Executive Officer and Acting Chairman · 2026-09-09 A new finance chief whose first substantive job is stretching the cash burn runway is a different company than a new finance chief hired to scale a winning model. The only concrete number on the cost side was the $2 million savings targeted for 2027 — and when Scott Henry of AGP asked where in the P&L it would land, Nathanzon was direct: “probably most of the expenses would be reflected in the operating expenses. Some of them in the COGS, but most of them in the OpEx.” — Guy Nathanzon, Chief Financial Officer · 2026-09-09 This is a margin-band-aid, not a manufacturing breakthrough.What Actually Moved Was Placements, Not Revenue
The operational update came from Meltzer, and it was a list, not a number: Greece, Romania, the Czech Republic installed; Peru and Argentina sitting on import licenses; a U.S. machine converted from subscription to capital sale; and three systems dropped into the Nanox Imaging Network. His framing — “in a nutshell, that's where we are. So, quite nice progress in the last quarter” — Erez Meltzer, Chief Executive Officer and Acting Chairman · 2026-09-09 — is the same vocabulary the company has used for several quarters now. The keywords capture the pivot: the company's own prior-quarter lexicon leaned heavily on Health IT, system sales, and commercial agreements, but this quarter's top-NNOX terms have flattened out to mundane plumbing — accounting rules, opex, and the Imaging Network. When a growth story's fresh keyword is "accounting rules," it is not a growth quarter. Older standbys the company once headlined — teleradiology, OEM services, and the broader Nanox Health IT line — barely surfaced at all in this call, an odd absence given teleradiology has historically been the profitable workhorse. The revenue mix is quietly drifting away from the recurring services that carry gross margin, at least narratively.A Thin Room, and a Refusal to Answer
The single most revealing moment was what management declined to say. Asked point-blank to size the operating expense base and how much could be pulled out, Nathanzon dodged:That is the correct answer for an incoming CFO who hasn't finished the review — but it also means the entire cost narrative is unquantified. Only two analysts asked questions all call (Ladenburg and AGP); prior quarters ran four to five questioners including Cantor Fitzgerald. Coverage is thinning alongside the story. The call itself was also audibly awkward — overlapping mics, Meltzer asking "Can you hear me?" twice, and a reimbursement answer that confused CMS pathways for the AI product versus the Imaging Network. For a company selling a disruptive imaging platform, the polish wasn't there.I'll try to be very cautious at this point, and if it's okay for you, I prefer not to answer this question directly. Once we have something to announce, we'll probably announce... There is no number that I can specifically announce right now.